Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
FEBS Letters|July 9, 1984
Some properties of a purinergic receptor solubilized from human uterus membranesS Ronca-Testoni, P Galbani, M Gambacciani
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 22, 2005
Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetateM Gambacciani, D Spielmann, A R Genazzani
Climacteric : the Journal of the International Menopause Society|October 9, 2001
Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, ItalyA R Genazzani, A Gadducci, M Gambacciani
Climacteric : the Journal of the International Menopause Society|July 27, 2007
The HRT misuse and osteoporosis epidemic: a possible future scenarioM Gambacciani, M Ciaponi, A R Genazzani
Neuroendocrinology|January 1, 1986
GnRH release from the mediobasal hypothalamus. In vitro regulation by oxytocinM Gambacciani, S S Yen, D D Rasmussen
Neuroendocrinology|January 1, 1986
GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factorM Gambacciani, S S Yen, D D Rasmussen
Life Sciences|January 1, 1988
GnRH stimulates ACTH and immunoreactive beta-endorphin release from the rat pituitary in vitroM Gambacciani, S S Yen, D D Rasmussen
Climacteric : the Journal of the International Menopause Society|July 30, 2019
Tailored hormonal approach in women with premature ovarian insufficiencyF Fruzzetti, G Palla, M Gambacciani, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 24, 2003
Hormone replacement therapy and endometrial, ovarian and colorectal cancerM Gambacciani, P Monteleone, A Sacco, et al.
American Journal of Obstetrics and Gynecology|November 22, 2001
Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal womenM Gambacciani, M Ciaponi, B Cappagli, et al.
Pageof 10